אדסל פוליו

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); FIMBRAE TUPES 2 + 3 (FIM); INACTIVATED POLIO VIRUS (IPV) TYPE 1; INACTIVATED POLIO VIRUS (IPV) TYPE 2; INACTIVATED POLIO VIRUS (IPV) TYPE 3; PERTACTIN (PRN); PERTUSSIS TOXOID VACCINE; TETANUS TOXOID

Available from:

SANOFI ISRAEL LTD

ATC code:

J07CA02

Pharmaceutical form:

תרחיף להזרקה

Composition:

FIMBRAE TUPES 2 + 3 (FIM) 5 MCG/DOSE; PERTUSSIS TOXOID VACCINE 2.5 MCG/DOSE; FILAMENTOUS HAEMAGGLUTININ (FHA) 5 MCG/DOSE; PERTACTIN (PRN) 3 MCG/DOSE; DIPHTHERIA TOXOID 2 LF / 1 DOSES; TETANUS TOXOID 5 LF / 1 DOSES; INACTIVATED POLIO VIRUS (IPV) TYPE 1 40 DU/DOSE; INACTIVATED POLIO VIRUS (IPV) TYPE 2 8 DU/DOSE; INACTIVATED POLIO VIRUS (IPV) TYPE 3 32 DU/DOSE

Administration route:

תוך-שרירי

Prescription type:

מרשם נדרש

Manufactured by:

SANOFI PASTEUR, FRANCE

Therapeutic group:

DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS

Therapeutic area:

DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS

Therapeutic indications:

Active immunization against diphtheria, tetanus, pertussis and poliomyelitis in subjects aged 3 years and over as a booster following primary immunisation . Adacel polio is not indicatd for primary immunisation. Adacel polio is not indicated for treating diseases caused by B. pertussis, C.Diphtheriae or c. tetani or by poliomyelitis infections.

Authorization date:

2015-01-31